Electromed (ELMD) Tops Q3 EPS by 2c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/22/2026
- S&P 500, Nasdaq end sharply lower as revived AI doubts ignite tech selloff
- Meta’s new Class C stock to keep Zuckerberg in California, fund AI spending spree
- Oil hits five-month high as Houthi attacks stoke supply fears
- Meta beats Q3 estimates, approves new nonvoting share class as AI spending surges
- Tesla stock up as automotive gross margin improves, free cash flow turns positive
- Abbott plans to spin off its nutrition unit as a standalone public company
- AMD shares fall amid AI chip sector selloff
- Alphabet shares drop ahead of earnings next week
- Bloom Energy Corp. (BE) Tops Q3 EPS by 25c, Beats on Revenue; Offers FY26 Guidance
- JetBlue shares fall amid American results, fuel cost concerns
Electromed, Inc. Announces Fiscal 2023 Third Quarter Results
May 9, 2023 4:05 PM EDTQuarterly Net Revenue Increase of 19% Year-over-Year
NEW PRAGUE, Minn.--(BUSINESS WIRE)-- Electromed, Inc. (Electromed) (NYSE American: ELMD), a leader in innovative airway clearance technologies, today announced financial results for the three months ended March 31, 2023 (Q3 FY 2023).
Q3 FY 2023 Highlights
Record quarterly net revenues of $12.1 million, a 19% year-over-year increase Homecare revenue of $11.0 million, an increase of 21% year-over-year Generated operating income of $1.2 million, an increase of 39% year-over-year Net income of $1.1 million, or $0.12 per fully diluted share, compared with net... More


